| Project/Area Number |
25860637
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Respiratory organ internal medicine
|
|---|
| Research Institution | Niigata University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | fibulin-3 / 胸膜中皮腫 / SMRP / 腫瘍マーカー |
|---|
| Outline of Final Research Achievements |
Fibulin-3 concentration in plasma and pleural effusion is expected as a new biomarker very high accuracy in the diagnosis of pleural mesothelioma. Our study fibulin-3, have similar reliability in Japanese diagnosis, it is an object to verify can be used in therapy evaluation.
Analyte accumulation of this study was approved by the applicant as a clinical trial at the Niigata University Medical and Dental Hospital. Pleural mesothelioma, as patients with such lung, blood, performs sampling of pleural effusion specimen, to obtain a 113 sample in accordance with the up to now. Mesothelioma patient save serum in the in addition to our department be added fibulin-3 as well as the SMRP, was carried out the analysis, such as CYFRA-21. Society announced during the year, are scheduled to paper reduction.
|
